Skip to main content
Book cover

Andrology pp 457–467Cite as

Empirical Therapies for Idiopathic Male Infertility

  • Chapter

Abstract

The collective diagnosis of “idiopathic infertility” most likely comprises a multitude of different pathogenic mechanisms. One of andrology's most important and exciting tasks is to disclose the workings of these mechanisms und ultimately to eliminate their cause by rational therapy. New points of departure are expected from research on molecular genetics and biological regulation of spermatogenesis; the effects of gonado-tropins and sex hormones at the molecular level, and the biology of the gametes. Examples of such accomplishments of research are the microdeletions of the Y chromosome, the CFTR mutations in congenital bilateral aplasia of the vas deferens (CBAVD) and the pathology of the androgen receptor.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Abdelmassih R, Dhont M, Comhaire F (1992) Pilot study with 120 mg Andriol treatment for couples with a low fertilization rate during in-vitro fertilization. Hum Reprod 7:267–268

    CAS  PubMed  Google Scholar 

  • Acosta A, Khalifa E, Oehninger S (1992) Pure human follicle stimulating hormone has a role in the treatment of severe male infertility by assisted reproduction: Norfolk's total experience. Hum Reprod 7:1067–1072

    CAS  PubMed  Google Scholar 

  • Adamopoulos DA, Nicopoulou S, Kapolla N, Karamertzanis M, Andreou E (1997) The combination of testosterone unde-canoate with tamoxifen citrate enhances the effects of each agent given independently on seminal parameters in men with idiopathic oligozoospermia. Fertil Steril 67:756–762

    Article  CAS  PubMed  Google Scholar 

  • Adamopoulos DA, Pappa A, Billa E, Nicopoulou S, Koukkou E, Michopoulos J (2003) Effectiveness of combined tamoxifen citrate and testosterone undecanoate treatment in men with idiopathic oligozoospermia. Fertil Steril 80:914–920

    Article  PubMed  Google Scholar 

  • Afjes JH, van der Vijver JC, Brugman FW, Schenck PE (1983) Double-blind cross over treatment with mesterolone and placebo of subfertile oligozoospermic men value of testicular biopsy. Andrologia 15:531–535

    Article  Google Scholar 

  • Ainmelk Y, Belisle S, Carmel M, JP Tetrault (1987) Tamoxifen citrate therapy in male infertility. Fertil Steril 48:113–127

    CAS  PubMed  Google Scholar 

  • Aitken RJ (1995) Free radicals, lipid peroxidation and sperm function. Reprod Fertil Dev 7:659–668

    Article  CAS  PubMed  Google Scholar 

  • Attia AM, Al-Inany HG, Proctor ML (2007) Gonadotrophins for idiopathic male factor subfertility. Cochrane Database Syst Rev 2007 CD00 5071

    Google Scholar 

  • Baccetti B, Piomboni P, Bruni E, Capitani S, Gambera L, Moretti E, Sterzik K, Strehler E (2004) Effect of follicle-stimulating hormone on sperm quality and pregnancy rate. Asian JAndrol 6:133–137

    CAS  Google Scholar 

  • Bals-Pratsch M, Knuth UA, Hönigl W, Klein HM, Bergmann M, Nieschlag E (1989) Pulsatile GnRH-therapy in oligozoospermic men does not improve seminal parameters despite decreased FSH levels. Clin Endocrinol 30:549–560

    Article  CAS  Google Scholar 

  • Bartoov B, Har-Even D, Eltes F, Lederman H, Lunenfeld E, Lunenfeld B (1994) Sperm quality of subfertile males before and after treatment with human follicle-stimulating hormone. Fertil Steril 61:727–734

    CAS  PubMed  Google Scholar 

  • Byrne MM, Rolf C, Depenbusch M, Cooper TG, Nieschlag E (2003) Lack of effect of a single i.v. dose of oxytocin on sperm output in severely oligozoospermic men. Hum Reprod 18:2098–2102

    Article  CAS  PubMed  Google Scholar 

  • Carani C, Granata AR, De RosaM, Garau C, Zarrilli S, Paesano L, Colao A, Marrama P, Lombardi G (1999) The effect of chronic treatment with GH on gonadal function in men with isolated GH deficiency. Eur J Endocrinol 140:224–230

    Article  CAS  PubMed  Google Scholar 

  • Clark R, Sherins RJ (1989) Treatment of men with idiopathic oligozoospermic infertility using the aromatase inhibitor testolactone. Results of a double-blinded, randomized, placebo-controlled trial with crossover. JAndrol 10:240–347

    CAS  Google Scholar 

  • Colao A, Marzullo P, Piezia S, Ferone D, Giaccio A, Cerbone G, Pivonello R, Di Somma C, Lombardi G (1999) Effect of growth hormone (GH) and insulin-like growth factor I on prostate diseases: An ultrasonographic and endocrine study in acromegaly, GH deficiency, and healthy subjects. J Clin Endocrinol Metab 84:1986–1991

    Article  CAS  PubMed  Google Scholar 

  • Comhaire FH (1990) Treatment of idiopathic testicular failure with high-dose testosterone undecanoate: A double blind pilot study. Fertil Steril 54:689–693

    CAS  PubMed  Google Scholar 

  • Comhaire F, Schoonjans F, Abdelmassih R, Gordts S, Campo R, Dhont M, Milingos S, Gerris J (1995) Does treatment with testosterone undecanoate improve the in-vitro fertilizing capacity of spermatozoa in patients with idiopathic testicular failure (results of a double-blind study). Hum Reprod 10:2600–2602

    CAS  PubMed  Google Scholar 

  • Comodo F, Vargiu N, Farina M (1996) Double-blind FSH-HP/ Placebo treatment of severe male factor related infertility: Effect on sperm parameters and IVF/ICSI outcome. ESHRE Abstract Book S41

    Google Scholar 

  • Dawson EB, Harris WA, Teter MC, Powell LC (1992) Effect of ascorbic acid supplementation on the sperm quality of smokers. Fertil Steril 58:1034–1039

    CAS  PubMed  Google Scholar 

  • Foresta C, Bettella A, Ferlin A, Garolla A, Rossato M (1998) Evidence for a stimulatory role of follicle-stimulating hormone on the spermatogonial population in adult males. Fertil Steril 69:636–642

    Article  CAS  PubMed  Google Scholar 

  • Foresta C, Bettella A, Merico M, Garolla A, Plebani M, Ferlin A, Rossato M (2000) FSH in the treatment of oligozoo-spermia. Mol Cell Endocrinol 161:89–97

    Article  CAS  PubMed  Google Scholar 

  • Foresta C, Bettella A, Merico M, Garolla A, Ferlin A, Rossato M (2002) Use of recombinant human follicle-stimulating hormone in the treatment of male factor infertility. Fertil Steril 77:238–244

    Article  PubMed  Google Scholar 

  • Foresta C, Bettella A, Garolla A, Ambrosini G, Ferlin A (2005) Treatment of male idiopathic infertility with recombinant human follicle-stimulating hormone: A prospective, controlled, randomized clinical study. Fertil Steril 84:654–661

    Article  CAS  PubMed  Google Scholar 

  • Gerris J, Comhaire F, Hellemans P, Peeters K, Schoonjans F (1991) Placebo controlled trial of high dose Mesterolone treatment of male infertility. Fertil Steril 55:603–607

    CAS  PubMed  Google Scholar 

  • Glezermann M, Huleihel M, Lunenfeld E, Soffer Y, Potashnik G, Segal S (1993) Efficacy of kallikrein in the treatment of oligozoospermia and asthenozoospermia: A double-blind trial. Fertil Steril 60:1052–1056

    Google Scholar 

  • Greco E, Romano S, Iacobelli M, Ferrero S, Baroni E, Minasi MG, Ubaldi F, Rienzi L, Tesarik J (2005) ICSI in cases of sperm DNA damage: beneficial effect of oral antioxidant treatment. Hum Reprod 20:2590–2594

    Article  CAS  PubMed  Google Scholar 

  • Gregoriou O, Papadias C, Gargaropoulos A, Konidaris S, Kontogeorgi Z, Kalampokas E (1993) Treatment of idiopathic infertility with testosterone undecanoate. A double blind study. Clin Exp Obstet Gynecol 20:9–12

    CAS  PubMed  Google Scholar 

  • Gregoriou O, Vitoratos N, Papadias C, Gargaropoulos A, Konidaris S, Giannopoulos V, Chryssicopoulos A (1997) Treatment of idiopathic oligozoospermia with an alpha-blocker: A placebo-controlled double-blind trial. Int J Fertil Womens Med 42:301–305

    CAS  PubMed  Google Scholar 

  • Heite HG (1979) The effect of Trental on spermiografic parameters, a clinical study in patients with reduced fertility. Fertil Steril 20(Suppl. 1):38–42

    Google Scholar 

  • Jung A, Schuppe HC (2007) Influence of genital heat stress on semen quality in humans. Andrologia 39:203–215

    Article  CAS  PubMed  Google Scholar 

  • Kamischke A, Nieschlag E (1999) Analysis of medical treatment of male infertility. Hum Reprod 14(Suppl 1):1–23

    Article  PubMed  Google Scholar 

  • Kamischke A, Behre HM, Bergmann M, Simoni M, Schäfer T, Nieschlag E (1998) Recombinant human follicle-stimulating hormone for treatment of male idiopathic infertility: A randomized, double-blind, placebo-controlled, clinical trial. Hum Reprod 13:596–603

    Article  CAS  PubMed  Google Scholar 

  • Keck C, Behre HM, Jockenhövel F, Nieschlag E (1994) Ineffectiveness of kallikrein in treatment of idiopathic male infertility: A double-blind, randomized, placebo-controlled trial. Hum Reprod 9:325–329

    CAS  PubMed  Google Scholar 

  • Kessopoulou E, Russel JM, Powers HJ, Cooke ID, Sharma KK, Barratt CLR, Pearson MJ (1995) A double-blind randomized placebo cross-over controlled trial using the antioxidant vitamin E to treat reactive oxygen species associated male infertility. Fertil Steril 64:825–831

    CAS  PubMed  Google Scholar 

  • Knuth UA, Hönigl W, Bals-Pratsch M, Schleicher G, Nieschlag E (1987) Treatment of severe ologozoospermia with hCG/ hMG. A placebo-controlled double-blind trial. J Clin Endocrinol Metab 65:1081–1087

    Article  CAS  PubMed  Google Scholar 

  • Krause W, Holland-Moritz H, Schramm P (1992) Treatment of idiopathic oligozoospermia with tamoxifen. A randomized controlled study. Int J Androl 15:14–18

    Article  CAS  PubMed  Google Scholar 

  • Lenzi A, Culasso F, Gandini L, Lombardo F, Dondero F (1993) Placebo-controlled, double-blind, cross-over trial of glutathione therapy in male infertility. Hum Reprod 8:1657–1662

    CAS  PubMed  Google Scholar 

  • Lenzi A, Lombardo F, Sgrò P, Salacone P, Caponecchia L, Dondero F, Gandini L (2003) Use of carnitine therapy in selected cases of male factor infertility: A double-blind crossover trial. Fertil Steril 79:292–300

    Article  PubMed  Google Scholar 

  • Lenzi A, Sgrò P, Salacone P, Paoli D, Gilio B, Lombardo F, Santulli M, Agarwal A, Gandini L (2004) A placebo-controlled double-blind randomized trial of the use of combined L-carnitine and L-acetyl-carnitine treatment in men with asthenozoospermia. Fertil Steril 81:1578–1584

    Article  CAS  PubMed  Google Scholar 

  • Matorras R, Perez C, Corcostegui B, Pijoan JI, Ramon O, Delgado P, Rodriguez-Escudero FJ (1997) Treatment of the male with follicle-stimulating hormone in intrauterine insemination with husband's spermatozoa: A randomized study. Hum Reprod 12:24–28

    Article  CAS  PubMed  Google Scholar 

  • Mauss J (1974) Ergebnisse der Behandlung von Fertil-itätsstörungen des Mannes mit Mesterolon oder einem Placebo. Arzneim Forsch 24:1338–1341

    CAS  Google Scholar 

  • Micic S, Dotlic R (1985) Evaluation of sperm parameters in clinical trial with clomiphene citrate of oligospermic men. JUrol 133:221–222

    CAS  Google Scholar 

  • Ng EH, So WS, Gao J, Wong YY, Ho PC (2008) The role of acupuncture in the management of subfertility. Fertil Steril 90:1–13

    Article  PubMed  Google Scholar 

  • Paradisi R, Busacchi P, Seracchioli R, Porcu E, Venturoli, S (2006) Effects of high doses of recombinant human follicle-stimulating hormone in the treatment of male factor infertility: Results of a pilot study. Fertil Steril 86:728–731

    Article  CAS  PubMed  Google Scholar 

  • Patel SR, Sigman M (2008) Antioxidant therapy in male infertility. Urol Clin North Am 35:319–330

    Article  PubMed  Google Scholar 

  • Pusch H (1989) Oral treatment of oligozoospermia with testos-terone-undecanoate: Results of a double blind study. Arch Androl 2:479–486

    Google Scholar 

  • Reyes-Fuentes A, Chavarria ME, Carrera A, Aguilera G, Rosado A,SamojlikE,IranmaneshA, Veldhuis JD (1996) Alterations in pulsatile luteinizing hormone and follicle-stimulating hormone secretion in idiopathic oligoasthenospermic men: Assessment by deconvolution analysis — a clinical research center study. J Clin Endocrinol Metab 81:524–529

    Article  CAS  PubMed  Google Scholar 

  • Rolf C, Behre HM, Nieschlag E (1996) Tamoxifen bei männli-cher Infertilität. Analyse einer fragwürdigen Therapie. Dtsch medWschr 121:33–39

    Article  CAS  Google Scholar 

  • Rolf C, Cooper TG, Yeung CH, Nieschlag E (1999) Antioxidant treatment of patients with asthenozoospermia or moderate oligoasthenozoospermia with high-dose vitamin C and vitamin E: A randomized, placebo-controlled, double-blind study. Hum Reprod 14:1028–1033

    Article  CAS  PubMed  Google Scholar 

  • Ronnberg, L (1980) The effect of clomiphene citrate on different sperm parameters and serum hormone levels in preselected infertile men: A controlled double-blind cross-over study. IntJAndrol 3:479–486

    CAS  Google Scholar 

  • Shen M-R, Chiang P-H, Yang R-C, Hong C-Y, Chen S-S (1991) Pentoxifylline stimulates human sperm motility both in vitro and after oral therapy. Br J Clin Pharmacol 31:711–714

    CAS  PubMed  Google Scholar 

  • SIG Scottish Infertility Group (1984) Randomized trial of mes-terolone versus vitamin C for male infertility. Br J Urol 56:740–744

    Article  Google Scholar 

  • Sigman M, Glass S, Campagnone J, Pryor JL (2006) Carnitine for the treatment of idiopathic asthenospermia: A randomized, double-blind, placebo-controlled trial. Fertil Steril 85:1409–1414

    Article  PubMed  Google Scholar 

  • Sokol RZ, Steiner BS, Bustillo M, Petersen G, Swerdloff RS (1988) A controlled comparison of the efficacy of clomiphene citrate in male infertility. Fertil Steril 49:865–870

    CAS  PubMed  Google Scholar 

  • Suleiman SA, Ali M, Zaki ZME, el-Malik EM, Nasir MA (1996) Lipid peroxidation and human sperm motility: Protective role of vitamin E. J Androl 17:530–537

    CAS  PubMed  Google Scholar 

  • Török L (1985) Treatment of oligozoospermia with tamoxifen (open and controlled studies). Andrologia 17:497–501

    PubMed  Google Scholar 

  • Tournaye H, Devroey P, Camus M, Van der Linden M, Janssens R, Van Steirteghem A (1995) Use of pentoxifylline in assisted reproductive technology. Hum Reprod 10(Suppl. 1):72–79

    CAS  PubMed  Google Scholar 

  • Tremellen K (2008) Oxidative stress and male infertility — a clinical perspective. Hum Reprod Update 14:243–258

    Article  CAS  PubMed  Google Scholar 

  • Vandekerckhove P, Lilford R, Hughes E (1998) The medical treatment of idiopathic oligo/asthenospermia: anti-oestrogens (clomiphene or tamoxifen) versus placebo or no treatment. In: Lilford R, Hughes E, Vandekerckhove P (eds) Subfertility Module of the Cochrane Database of Systematic Reviews.

    Google Scholar 

  • Cochrane Library. The Cochrane Collaboration, Issue 2. Update Software, Oxford

    Google Scholar 

  • Vandekerckhove P, Lilford R, Vail A, Hughes E (2000a) Kinin enhancing drugs for unexplained subinfertility. The Cochrane Collaboration, Database Syst Rev 2000 CD 153

    Google Scholar 

  • Vandekerckhove P, Lilford R, Vail A, Hughes E (2000b) Bromocriptine foridiopathic oligo/asthenospermia. Cochrane Database Syst Rev CD 152

    Google Scholar 

  • Vandekerckhove P, Lilford R, Vail A, Hughes E (2007) Clomiphene or tamoxifen for idiopathic oligo/asthenospermia. Cochrane Database Syst Rev CD 151

    Google Scholar 

  • Wagner ROF, Warsch F (1984) Pulsatile LHRH therapy of “slow pulsing oligospermia”: Indirect evidence for a hypothalamic origin of the disorder. Acta Endocrinol (Copenh) 105(Suppl 264): 142–145

    Google Scholar 

  • Walch K, Eder R, Schindler A, Feichtinger W (2001) The effect of single-dose oxytocin application on time to ejaculation and seminal parameters in men. J Assist Reprod Genet 18:655–659

    Article  CAS  PubMed  Google Scholar 

  • Wang C, Chan CW, Wong KK, Yeung KK (1983) Comparison of the effectiveness of placebo, clomiphene citrate, mesterolone, pentoxyfylline and testosterone rebound therapy for the treatment of idiopathic oligospermia. Fertil Steril 40:358–365

    CAS  PubMed  Google Scholar 

  • WHO Task Force on the Diagnosis and Treatment of Infertility (1989) Mesterolone and idiopathic male infertility: A double-blind study. Int J Androl 12:254–264

    Article  Google Scholar 

  • WHO Task Force on the Prevention and Management of Infertility (1992) A double-blind trial of clomiphene citrate for the treatment of idiopathic male infertility. Int J Androl 15:299–307

    Article  Google Scholar 

  • Yamamoto M, Hibi H, Mijake K (1995) Comparison of the effectiveness of placebo and a-blocker therapy for treatment of idiopathic oligozoospermia. Fertil Steril 63:396–340

    CAS  PubMed  Google Scholar 

  • Yamamoto M, Katsuno S, Hibi H, Miyake K (1996) The lack of effectiveness of kallikrein in the treatment of idiopathic oligozoospermia: A double-blind, randomized, placebo-controlled study. Jap J Fertil Steril 41:1–6

    CAS  Google Scholar 

  • Yeung CH, De Geyter C, De Geyter M, Nieschlag E (1996) Production of reactive oxygen species by and hydrogen peroxide scavenging activity of spermatozoa in an IVF program. J Assist Reprod Genet 13:495–500

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eberhard Nieschlag .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Nieschlag, E., Kamischke, A. (2010). Empirical Therapies for Idiopathic Male Infertility. In: Nieschlag, E., Behre, H.M., Nieschlag, S. (eds) Andrology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-78355-8_22

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-78355-8_22

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-78354-1

  • Online ISBN: 978-3-540-78355-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics